Mihail Obrocea - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Medical Officer
Signature
/s/ Mihail Obrocea
Issuer symbol
MAIA
Transactions as of
27 Jul 2022
Transactions value $
$0
Form type
3
Date filed
27 Jul 2022, 18:32
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MAIA Common Stock 26.1K 27 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MAIA Options 27 Jul 2022 Common Stock 13.3K $1.80 Direct F2
holding MAIA Options 27 Jul 2022 Common Stock 6.13K $1.80 Direct F2
holding MAIA Options 27 Jul 2022 Common Stock 10K $1.83 Direct F2
holding MAIA Options 27 Jul 2022 Common Stock 7.45K $1.83 Direct F3
holding MAIA Options 27 Jul 2022 Common Stock 6.48K $1.83 Direct F4
holding MAIA Options 27 Jul 2022 Common Stock 260K $1.83 Direct F5
holding MAIA Option 27 Jul 2022 Common Stock 7.44K $1.83 Direct F6
holding MAIA Options 27 Jul 2022 Common Stock 772 $8.00 Direct F7
holding MAIA Warrants 27 Jul 2022 Common Stock 8.82K $6.00 Direct F8
holding MAIA Warrants 27 Jul 2022 Common Stock 4.23K $6.00 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Obrocea beneficially owns 26,100 shares of common stock.
F2 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 11, 2021.
F3 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 7, 2021.
F4 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 5, 2021.
F5 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. 25% of these options vest in 1 year with the remaining options vesting in 36 equal monthly installments beginning on July 15, 2021.
F6 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 30, 2021.
F7 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on July 31, 2021.
F8 Each Warrant became exercisable on the date of issuance of October 10, 2020, and expire on the earliest to occur of: (a) October 10, 2027 or (b) immediately prior to the closing of any change of control of the issuer.
F9 Each Warrant became exercisable on the date of issuance of June 29, 2021, and expire on the earliest to occur of: (a) June 28, 2028 or (b) immediately prior to the closing of any change of control of the issuer.